The wire › SEC Form 8-K
LAVA Therapeutics NV LVTX
Filed with the SEC on Nov 21, 2025. Reported event date Nov 21, 2025.
- Business address
- Utrecht
- State
- Outside the U.S. or not given
- Incorporated in
- Outside the U.S. or not given
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1840748
- Accession number
- 0001104659-25-114793
Items reported in this filing
- Item 2.01 Completion of Acquisition or Disposition of Assets
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 3.03 Material Modification to Rights of Security Holders
- Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
Other entries on the wire for this company
-
LAVA Therapeutics NV LVTX
-
LAVA Therapeutics NV LVTX
-
LAVA Therapeutics NV LVTX
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing